Establishment Labs Holdings Inc. (ESTA) is a publicly traded Healthcare sector company. As of May 21, 2026, ESTA trades at $69.99 with a market cap of $1.93B and a P/E ratio of -46.80. ESTA moved +6.93% today. Year to date, ESTA is +5.43%; over the trailing twelve months it is +85.98%. Its 52-week range spans $26.56 to $83.31. Analyst consensus is strong buy with an average price target of $89.57. Rallies surfaces ESTA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Establishment Labs Reports Robust Q1 2026 Revenue Growth Fuelled by Implant Sales: Establishment Labs Holdings Inc posted strong revenue growth in Q1 2026, driven by increased implant sales across its core markets. Management highlighted expanded market penetration and robust top-line performance during its quarterly earnings call.
| Metric | Value |
|---|---|
| Price | $69.99 |
| Market Cap | $1.93B |
| P/E Ratio | -46.80 |
| EPS | $-1.48 |
| Dividend Yield | 0.00% |
| 52-Week High | $83.31 |
| 52-Week Low | $26.56 |
| Volume | 116 |
| Avg Volume | 0 |
| Revenue (TTM) | $229.58M |
| Net Income | $-43.74M |
| Gross Margin | 70.06% |
7 analysts cover ESTA: 0 strong buy, 6 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $89.57.